GB0307259D0 - Process - Google Patents

Process

Info

Publication number
GB0307259D0
GB0307259D0 GBGB0307259.2A GB0307259A GB0307259D0 GB 0307259 D0 GB0307259 D0 GB 0307259D0 GB 0307259 A GB0307259 A GB 0307259A GB 0307259 D0 GB0307259 D0 GB 0307259D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0307259.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0307259.2A priority Critical patent/GB0307259D0/en
Publication of GB0307259D0 publication Critical patent/GB0307259D0/en
Priority to MXPA05010413A priority patent/MXPA05010413A/es
Priority to BRPI0408752-6A priority patent/BRPI0408752A/pt
Priority to CA002520249A priority patent/CA2520249A1/en
Priority to CNA2004800083916A priority patent/CN1768057A/zh
Priority to OA1200500267A priority patent/OA13042A/en
Priority to EP04723254A priority patent/EP1615918A1/en
Priority to US10/551,021 priority patent/US20070167494A1/en
Priority to AU2004224068A priority patent/AU2004224068A1/en
Priority to KR1020057018143A priority patent/KR20050120670A/ko
Priority to PCT/GB2004/001306 priority patent/WO2004085435A1/en
Priority to EA200501527A priority patent/EA009331B1/ru
Priority to JP2006506028A priority patent/JP2006521340A/ja
Priority to ZA200507100A priority patent/ZA200507100B/en
Priority to EC2005006038A priority patent/ECSP056038A/es
Priority to MA28549A priority patent/MA27727A1/fr
Priority to NO20054911A priority patent/NO20054911L/no
Priority to IS8087A priority patent/IS8087A/is
Priority to AU2008237610A priority patent/AU2008237610A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
GBGB0307259.2A 2003-03-28 2003-03-28 Process Ceased GB0307259D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GBGB0307259.2A GB0307259D0 (en) 2003-03-28 2003-03-28 Process
JP2006506028A JP2006521340A (ja) 2003-03-28 2004-03-25 ロシグリタゾン・マレイン酸塩の多形体の製法
AU2004224068A AU2004224068A1 (en) 2003-03-28 2004-03-25 Process for preparing a polymorph of rosiglitazone maleate
PCT/GB2004/001306 WO2004085435A1 (en) 2003-03-28 2004-03-25 Process for preparing a polymorph of rosiglitazone maleate
CA002520249A CA2520249A1 (en) 2003-03-28 2004-03-25 Process for preparing a polymorph of rosiglitazone maleate
CNA2004800083916A CN1768057A (zh) 2003-03-28 2004-03-25 罗格列酮马来酸盐多晶型物的制备方法
OA1200500267A OA13042A (en) 2003-03-28 2004-03-25 Process for preparing a polymorph of rosiglitazonemaleate.
EP04723254A EP1615918A1 (en) 2003-03-28 2004-03-25 Process for preparing a polymorph of rosiglitazone maleate
US10/551,021 US20070167494A1 (en) 2003-03-28 2004-03-25 Process for preparing a polymorph or rosiglitazone maleate
MXPA05010413A MXPA05010413A (es) 2003-03-28 2004-03-25 Procedimiento para la preparacion de un polimorfo de maleato de rosiglitazona.
KR1020057018143A KR20050120670A (ko) 2003-03-28 2004-03-25 로시글리타존 말레에이트의 다형체의 제조 방법
BRPI0408752-6A BRPI0408752A (pt) 2003-03-28 2004-03-25 processo para o preparo de um polimorfo de maleato de rosiglitazona
EA200501527A EA009331B1 (ru) 2003-03-28 2004-03-25 Способ получения полиморфа малеата розиглитазона
ZA200507100A ZA200507100B (en) 2003-03-28 2005-09-05 Process for preparing a polymorph of rosigitazone maleate
EC2005006038A ECSP056038A (es) 2003-03-28 2005-09-26 Procedimiento para la preparación de un polimorfo de maleato de rosiglitazona
MA28549A MA27727A1 (fr) 2003-03-28 2005-10-11 Procede de preparation d'un polymorphe de maleate de rosiglitazone
NO20054911A NO20054911L (no) 2003-03-28 2005-10-24 Fremgangsmate for fremstilling av et polymorft frosiglitazonmaleat
IS8087A IS8087A (is) 2003-03-28 2005-10-24 Aðferð til að framleiða fjölgerving rósiglítasónmaleats
AU2008237610A AU2008237610A1 (en) 2003-03-28 2008-10-30 Process for preparing a polymorph of rosiglitazone maleate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0307259.2A GB0307259D0 (en) 2003-03-28 2003-03-28 Process

Publications (1)

Publication Number Publication Date
GB0307259D0 true GB0307259D0 (en) 2003-05-07

Family

ID=9955778

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0307259.2A Ceased GB0307259D0 (en) 2003-03-28 2003-03-28 Process

Country Status (18)

Country Link
US (1) US20070167494A1 (https=)
EP (1) EP1615918A1 (https=)
JP (1) JP2006521340A (https=)
KR (1) KR20050120670A (https=)
CN (1) CN1768057A (https=)
AU (2) AU2004224068A1 (https=)
BR (1) BRPI0408752A (https=)
CA (1) CA2520249A1 (https=)
EA (1) EA009331B1 (https=)
EC (1) ECSP056038A (https=)
GB (1) GB0307259D0 (https=)
IS (1) IS8087A (https=)
MA (1) MA27727A1 (https=)
MX (1) MXPA05010413A (https=)
NO (1) NO20054911L (https=)
OA (1) OA13042A (https=)
WO (1) WO2004085435A1 (https=)
ZA (1) ZA200507100B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
WO2018140092A1 (en) 2017-01-27 2018-08-02 Obrien Christopher F Methods for the administration of certain vmat2 inhibitors
ES3024958T3 (en) 2017-09-21 2025-06-05 Neurocrine Biosciences Inc High dosage valbenazine formulation and compositions, methods, and kits related thereto
JP2021502959A (ja) 2017-10-10 2021-02-04 ニューロクライン バイオサイエンシーズ，インコーポレイテッド 特定のｖｍａｔ２インヒビターを投与するための方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
UA67844C2 (uk) * 1999-04-23 2004-07-15 Смітклайн Бічам Плс Поліморф 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти
PL351685A1 (en) * 1999-04-23 2003-06-02 Smithkline Beecham Plc Novel pharmaceutical
DE60004658T2 (de) * 1999-04-23 2004-06-24 Smithkline Beecham Plc, Brentford Thiazolidindionderivat und seine verwendung als antidiabetikum
CZ2003864A3 (cs) * 2000-09-26 2004-01-14 Dr. Reddy´S Research Foundation Nové polymorfní formy 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl]thiazolidin-2,4-dion-maleátu a způsob jejich přípravy

Also Published As

Publication number Publication date
OA13042A (en) 2006-11-10
IS8087A (is) 2005-10-24
EA200501527A1 (ru) 2006-02-24
EA009331B1 (ru) 2007-12-28
CN1768057A (zh) 2006-05-03
MXPA05010413A (es) 2005-11-04
BRPI0408752A (pt) 2006-03-28
ZA200507100B (en) 2006-07-26
NO20054911L (no) 2005-10-24
KR20050120670A (ko) 2005-12-22
AU2008237610A1 (en) 2008-11-27
US20070167494A1 (en) 2007-07-19
JP2006521340A (ja) 2006-09-21
AU2004224068A1 (en) 2004-10-07
WO2004085435A1 (en) 2004-10-07
EP1615918A1 (en) 2006-01-18
CA2520249A1 (en) 2004-10-07
MA27727A1 (fr) 2006-01-02
ECSP056038A (es) 2006-01-27

Similar Documents

Publication Publication Date Title
GB0325386D0 (en) Process
GB0325530D0 (en) Process
GB0306432D0 (en) Process
GB0324947D0 (en) Process
GB0313661D0 (en) Process
GB0322640D0 (en) Process
GB0316756D0 (en) Process
GB0303659D0 (en) Process
GB0314739D0 (en) Electrodeionisation process
GB0313110D0 (en) Process
GB0307259D0 (en) Process
GB0311725D0 (en) Process
GB0325526D0 (en) Process
GB0322648D0 (en) Process
GB0313031D0 (en) Process
GB0312451D0 (en) Process
GB0321240D0 (en) Process
GB0300733D0 (en) Process
GB0316872D0 (en) Process
GB0322559D0 (en) Process
GB0312925D0 (en) Process
GB0309471D0 (en) Process
GB0318236D0 (en) Process
GB0313256D0 (en) Process
GB0322636D0 (en) Process

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)